Patient selection for IGF-I therapy

Hormone Research

Volumn 65, Issue SUPPL. 1, 2006, Pages 28-34

  Clayton, P E ^a   Ayoola, O ^a   Whatmore, A J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 3;

BRAIN PSEUDOTUMOR; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COARSE FACE; DISEASE CLASSIFICATION; DRUG CHOICE; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HYPOGLYCEMIA; INSULIN LIKE GROWTH FACTOR 1 DEFICIENCY; LYMPHOID HYPERPLASIA; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW; SHORT STATURE;

FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PATIENT SELECTION;

EID: 33644611151     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090644     Document Type: Review

References (29)

1. Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bercu BB: Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA 1984;251:2223-2230.
2. Zadik Z, Chalew SA, Gilula Z, Kowarski AA: Reproducibility of growth hormone testing procedures: a comparison between 24-hour integrated concentration and pharmacological stimulation. J Clin Endocrinol Metab 1990;71:1127-1130.
3. Zadik Z, Chalew SA, Kowarski A: Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation. J Clin Endocrinol Metab 1990;71:932-936.
4. Zadik Z, Chalew SA, Kowarski A: The definition of a spontaneous growth hormone (GH) peak: studies in normally growing and GH-deficient children. J Clin Endocrinol Metab 1992;74:801-805.
5. Albertsson-Wikland K, Rosberg S: Analyses of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab 1988;67:493-500.
6. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T: Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab 1994;78:1195-1201.
7. Hindmarsh P, Smith PJ, Brook CG, Matthews DR: The relationship between height velocity and growth hormone secretion in short prepubertal children.Clin Endocrinol (Oxf) 1987;27:581-591.
8. Marin G, Domene HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler GB Jr: The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 1994;79:537-541.
9. Gill MS, Thalange NK, Foster PJ, Tillmann V, Price DA, Diggle PJ, Clayton PE: Regular fluctuations in growth hormone (GH) release determine normal human growth. Growth Horm IGF Res 1999;9:114-122.
10. Gill MS, Tillmann V, Veldhuis JD, Clayton PE: Patterns of GH output and their synchrony with short-term height increments influence stature and growth performance in normal children. J Clin Endocrinol Metab 2001;86:5860-5843.
11. Rosenfeld RG: Biochemical diagnostic strategies in the evaluation of short stature: the diagnosis of insulin-like growth factor deficiency. Horm Res 1996;46:170-173.
12. Clayton PE, Hall CM: Insulin-like growth factor I levels in healthy children. Horm Res 2004;62(suppl 1):2-7.
13. Hintz RL, Attie KM, Baptista J, Roche A: Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. N Engl J Med 1999;18;340:502-507.
14. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF: Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 2005;146:45-53.
15. Hintz RL: Growth hormone treatment of idiopathic short stature: clinical studies. Growth Horm IGF Res 2005;15(suppl A):S6-8.
16. Camacho-Hubner C, Underwood LE, Savage MO: Insulin-like growth factor-I treatment. ESPE/LWPES 7th Joint Meeting, Lyon, France, 2005. S10-40.
17. Bagi C, van der Meulen M, Brommage R, Rosen D, Sommer A: The effect of systemically administered rhIGF-I/IGFBP-3 complex on cortical bone strength and structure in ovariectomized rats. Bone 1995;16:559-565.
18. Svanberg E, Ohlsson C, Kimball SR, Lundholm K: rhIGF-I/IGFBP-3 complex, but not free rhIGF-I, supports muscle protein biosynthesis in rats during semistarvation. Eur J Clin Invest 2000;30:438-446.
19. van der Kamp HJ, Periera Arias AM, Walenkamp MJE, Kant SG, van Duyvenvoorde HA, Kruithof F, Breuning MH, Romijn JA, Karperien M, Wit JM: Variable degree of familial intrauterine and postnatal growth retardation due to a heterozygous missense mutation in the tyrosine kinase domain of the IGF-I receptor. Endocrine Society 87th Annual Meeting, San Diego, USA, 2005. P2-571.
20. van der Kamp HJ, Walenkamp MJE, Periera Arias AM, , Kant SG, van Duyvenvoorde HA, Kruithof F, Breuning MH, Romijn JA, Karperien M, Wit JM: A novel heterozygous missense mutation in the IGF-I receptor gene in a young female and her daughter, resulting in a variable degree of intrauterine growth retardation. ESPE/LWPES 7th Joint Meeting, Lyon, France, 2005. P2-572.21.
21. Attie KM, Carlsson LM, Rundle AC, Sherman BM: Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study. J Pediatr 1995;127:244-250.
22. Clayton PE, Freeth JS, Norman MR: Congenital growth hormone insensitivity syndromes and their relevance to idiopathic short stature. Clin Endocrinol (Oxf) 1999;50:275-283.
23. Bright GM, Attie KM, Julius JR, Kuntze J, Lippe BM, Clark RG, Rosenfeld RG: IGF-I deficiency: Prevalence and clinical characteristics amon short children. 7th International Congress of Endocrinology, Lisbon, Portugal, 2004. OR-84.
24. Hall CM, Gill MS, Foster P, Pennells L, Tillmann V, Jones J, Price DA,Clayton PE: Relationship between serum and urinary insulin-like growth factor-I through childhood and adolescence: their use in the assessment of disordered growth. Clin Endocrinol (Oxf) 1999;50:611-618.
25. Ranke MB, Lindberg A, Cowell CT, Wikland KA, Reiter EO, Wilton P, Price DA, KIGS International Board: Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). J Clin Endocrinol Metab 2003;88:125-131.
26. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA, KIGS International Board: Kabi International Growth Study. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. J Clin Endocrinol Metab 2000;85:4212-4218.
27. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ: Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996;335:1363-1367.
28. Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van Doorn J, Chen JW, Mohan S, Denley A, Forbes B, van Duyvenvoorde HA, van Thiel SW, Sluimers CA, Bax JJ, de Laat JA, Breuning MB, Romijn JA, Wit JM: Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 2005;90:2855-2864.
29. Goddard AD, Dowd P, Chernausek S, Geffner M, Gertner J, Hintz R, Hopwood N, Kaplan S, Plotnick L, Rogol A, Rosenfield R, Saenger P, Mauras N, Hershkopf R, Angulo M, Attie K: Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature. J Pediatr 1997;131:851-55.